Formoterol dry-powder inhalation - Chemo Iberica/IPAS

Drug Profile

Formoterol dry-powder inhalation - Chemo Iberica/IPAS

Alternative Names: Eformoterol dry-powder inhalation - Chemo Iberica/IPAS; Formoterol fumarate dry-powder inhalation - Chemo Iberica/IPAS

Latest Information Update: 23 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chemo Iberica; IPAS
  • Class
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 12 Nov 1999 Investigation in Asthma in Italy (Inhalation)
  • 12 Nov 1999 Investigation in Asthma in Switzerland (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top